Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01236417 · ClinicalTrials.gov registry record · NA

Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia

A NA study of Breast Cancer and Arthralgia, sponsored by Roswell Park Cancer Institute.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT01236417 is a NA study of Breast Cancer and Arthralgia that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 27 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01236417, a NA study of Breast Cancer and Arthralgia, has completed, sponsored by Roswell Park Cancer Institute.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.

Conditions Studied

Interventions

  • BEHAVIORAL Exercising block

Study Locations (1)

New York

  • Roswell Park Cancer Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2010-03
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT01236417

The ClinicalTrials.gov registry entry for NCT01236417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exercising block is the first listed.

NCT01236417 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01236417 about?

NCT01236417 is a clinical study titled "Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia". This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.

What is the current status of trial NCT01236417?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2010-03.

What conditions does trial NCT01236417 study?

This clinical trial studies the following conditions: Breast Cancer, Arthralgia.

What interventions are being tested in trial NCT01236417?

The interventions under investigation include: Exercising block (BEHAVIORAL).

Who is sponsoring clinical trial NCT01236417?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01236417 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.